Doctor profile · Federal record
Dr. Preethi John, MD
Medical Oncology Physician (CMS: Medical Oncology) · Dallas, TX
- NPI 1841553518
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 14 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
3410 Worth St Ste 400
Dallas, TX 752462092
(214) 370-1000
fax (214) 370-1986 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- June 2012 — 14 yrs on file
- Profile last updated
- May 23, 2022
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #S0467
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841553518. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
49,048
Distinct HCPCS
10
Medicare allowed
$1,197,844
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 12,200 | 40 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 10,050 | 58 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 5,820 | 11 | $30 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,527 | 54 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 5,496 | 31 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,617 | 118 | $0 | |
J1930 |
Injection, lanreotide, 1 mg | 1,560 | 11 | $55 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 930 | 77 | $1 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 730 | 11 | $43 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 570 | 44 | $0 |
In context: peer comparison
Among 27 peers in this city , average services per provider: 1,011. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$3,835
Transactions
59
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 1 | $1,750.00 | |
| Novartis Pharmaceuticals Corporation | 12 | $999.96 | |
| Daiichi Sankyo Inc. | 15 | $273.03 | |
| AstraZeneca Pharmaceuticals LP | 9 | $233.71 | |
| Stemline Therapeutics Inc. | 4 | $87.32 | |
| Tempus AI, Inc | 1 | $73.86 | |
| Merck Sharp & Dohme LLC | 2 | $60.36 | |
| ABBVIE INC. | 4 | $58.50 | |
| Genentech USA, Inc. | 3 | $57.68 | |
| Incyte Corporation | 2 | $46.02 | |
| Gilead Sciences, Inc. | 2 | $38.49 | |
| PFIZER INC. | 1 | $35.69 | |
| Karyopharm Therapeutics Inc. | 1 | $22.81 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $22.39 | |
| SERVIER PHARMACEUTICALS LLC | 1 | $22.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
726
Patients
166
Total drug cost
$1,205,799
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 300 | 85 | $8,123 |
| Letrozole | Generic | 225 | 69 | $6,787 |
| Tamoxifen Citrate | Generic | 41 | 12 | $658 |
| Ibrance (Palbociclib) | Brand | 34 | 0 | $656,868 |
| Verzenio (Abemaciclib) | Brand | 34 | 0 | $524,341 |
| Exemestane | Generic | 33 | 0 | $8,346 |
| Gabapentin | Generic | 31 | 0 | $356 |
| Escitalopram Oxalate | Generic | 17 | 0 | $208 |
| Ondansetron Odt (Ondansetron) | Brand | 11 | 0 | $110 |
Hospital affiliations
Frequently asked questions
What is Dr. Preethi John's medical specialty?
Dr. Preethi John practices Medical Oncology Physician in Dallas, TX.
Where does Dr. Preethi John practice?
Dr. Preethi John practices at 3410 Worth St Ste 400, Dallas, TX 752462092. Office phone: 2143701000.
What is Dr. Preethi John's NPI?
Dr. Preethi John's National Provider Identifier (NPI) is 1841553518, issued by NPPES.
Does Dr. Preethi John accept Medicare assignment?
Yes. Dr. Preethi John accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Preethi John commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.